Reata Pharma (RETA) Tops Q3 EPS by 67c

Reata Pharma (NASDAQ: RETA) reported Q3 EPS of ($1.31), $0.67 better than the analyst estimate of ($1.98).

For earnings history and earnings-related data on Reata Pharma (RETA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• SanDisk upgraded at JPMorgan after investor day; shares climb